The patient selection window spanned from 1 August 2020 to 31 December 2021 to include the earliest market launch dates of the dulaglutide higher doses and of oral semaglutide (January 2021 and August 2020, respectively)
& Marks, J
Patients can typically expect to lose approximately 5-10% of their body weight over the course of a year when using Contrave in conjunction with diet and exercise
Diabetes Mellitus Type 2: A chronic condition affecting blood sugar processing, associated with obesity and targeted by semaglutide and tirzepatide
IV infusions require longer chair time, specialized equipment, and clinical oversight, which increases cost
INS-1 832/3 SNAP/FLAG-hGLP-1R WT and V229A cells were generated in house from INS-1 832/3 GLP-1R KO cells following transfection with pSNAP/FLAG-hGLP-1R (Cisbio) or pSNAP/FLAG-hGLP-1R-V229A (generated in house by site-directed mutagenesis, see below), followed by selection with 1 mg/mL G418 sulphate (A1720, Sigma Aldrich)
